TrialClinical drug investigation2021

Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects.

Jane Knöchel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.